Status:
UNKNOWN
Variants of SARS-CoV-2 Causing COVID-19 in Africa
Lead Sponsor:
ANRS, Emerging Infectious Diseases
Collaborating Sponsors:
Institut de Recherche pour le Developpement
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The main objective of this research is to identify and characterize the different molecular variants of SARS-CoV-2, emerging and / or circulating in several countries of Sub-Saharan Africa (Burkina Fa...
Detailed Description
The main objective of this research is to identify and characterize the different molecular variants of SARS-CoV-2, emerging and / or circulating in several countries of Sub-Saharan Africa (Burkina Fa...
Eligibility Criteria
Inclusion
- Major subject (cf. country)
- Presenting for a SARS-COV-2 diagnosis, whether symptomatic or not
- Not objecting to participating in the research
Exclusion
- NA
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
12600 Patients enrolled
Trial Details
Trial ID
NCT05311891
Start Date
September 1 2022
End Date
October 1 2022
Last Update
May 27 2022
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de Référence pour les pathogènes émergents et réémergent
Bobo-Dioulasso, Burkina Faso, BP 2161
2
Centre Hospitalier Universitaire la Référence Nationale (CHU-RN)
N'Djamena, Chad, BP : 130
3
CIRBA
Abidjan, Côte d’Ivoire
4
Unité Mixte de Recherche CIRMF-SSM
Libreville, Gabon, 20404